Flash Sale! to get a free eCookbook with our top 25 recipes.

Meta Cell Technology: India’s 1st injectable exosome therapy

Meta Cell Technology: India’s 1st injectable exosome therapy
L to R: Mr Kalpesh Gawade- Founder & Managing Director Skinnovation Pvt Ltd, Dr Aparna Santhanam- Medical Operations Head Kaya, Dr Sunita Naik- Head Medical Advisor West Kaya.

Have you heard about the Meta Cell Technology (MCT)? It is the latest innovation which is launched by Kaya Skin Clinic in partnership with Skinnovation. MCT is a modern regenerative solution that helps make treatments safer, faster, and more effective. 

In a field that is always changing, MCT is a smart choice for clinics that want to stay ahead.

What is meta cell technology?

MCT uses the patient’s own natural cells to speed up the repair of skin and hair. It is the first technology in India to offer injectable autologous exosomes, which are powerful healing messengers taken from the patient’s own body. 

Unlike regular treatments, MCT gives a more personalised and proven approach that supports faster healing with less discomfort.

How does it work?

The process uses a simple yet advanced three-step method for both medical and aesthetic applications:

  • Blood sample collection: A small sample of the patient’s blood is taken to extract Platelet-Rich Plasma (PRP).
  • Processing PRP: Using the patented MCT Kit®, the PRP is refined to prepare for activation.
  • Activation: The PRP undergoes advanced photo-thermal conditioning in the MCT Unit®, where controlled light and temperature optimize the regenerative potential.

This process creates high-quality exosomes and growth factor-rich plasma, which boosts ATP production and improves platelet activity. The results? Quicker healing, noticeable results after just one session, and much less discomfort for patients.

Why should clinics consider it?

The MCT system works in three simple steps to give the best results with minimal discomfort:

  • Autologous and safe: Using the patient’s own cells drastically reduces side effect risks.
  • Clinically validated: Backed by rigorous scientific research, MCT is suitable for both aesthetic enhancement and medical dermatology.
  • Immediate and long-term results: Patients notice visible changes in hair loss, thinning, and skin quality from the initial treatment.
  • Efficient and practical: The simple process makes it easy for clinicians to operate and efficient for patients, improving operational workflows.

Industry perspectives

Kalpesh Gawade, Founder and Director of Skinnovation, describes MCT as more than just a treatment. This scientifically advanced, biology-based method delivers natural, safe, and effective aesthetic results.

Dr Aparna Santhanam, Head Medical Dermatologist and Vice President at Kaya Clinic believes MCT is the future of regenerative aesthetics. It delivers faster, personalised, and science-backed results with very little downtime.

The future of regenerative dermatology

Meta Cell Technology is becoming widely adopted in Indian clinics, transforming patient care in aesthetic dermatology. Clinics that embrace this innovation can stand out by delivering better patient experiences and clinically proven regenerative outcomes.